Bersot, T. P. (2011). Drug Therapy for Hypercholesterolemia and Dyslipidemia. In L. L. Brunton, B. A. Chabner, & B. C. Knollmann (Eds.), Goodman & Gilman’s: The Pharmacological Basis of Therapeutics (12th ed., pp. 893-898). McGraw-Hill Medical.
Briggs, G. G., & Freeman, R. K. (2015). A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation (10th ed., pp. 104-105). Wolters Kluwer Health.
Gotto, A. M., Jr., & Opie, L. H. (2013). Lipid-Modifying and Antiatherosclerotic Drugs. In L. H. Opie & B. J. Gersh (Eds.), Drugs for the Heart (8th ed., pp. 819-820). Elsevier Saunders.
Atorvastatin calcium. (2009). Pfizer Ireland Pharmaceuticals. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020702s056lbl.pdf
Central Drugs Standard Control Organisation (CDSCO). (n.d.). Atorvastatin. Retrieved from http://www.cdscoonline.gov.in
Atorvastatin Calcium [Prescribing Information]. (2022). Viatris Specialty LLC. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020702Orig1s079correctedlbl.pdf
McIver, L. A., & Siddique, M. S. (2021). Statpearls: Mechanism of Action of Atorvastatin. National Institute of Health, National Library of Medicine, National Center for Biotechnology Information. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK430779/